An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
Clinical trial NCT02632409 · COMPLETED
Trial details
- NCT number
- NCT02632409
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-22
- Primary completion
- 2020-07-17
- Enrollment
- 709
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.